TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
BIOA

BioAge Labs, Inc

Healthcare · Drug Manufacturers - Specialty & Generic · —

8.10$ -0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

BioAge Labs, Inc (BIOA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 295 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BIOA
Line item 2013 2014 2015 2016 2017 2022 2023 2024 2025
114 152 143 161 70 28 26 358 295
95 57 11 31 15 28 25 357 287
84 51 7.0 16 4.6 28 22 354 189
84 51 7.0 16 4.6 28 22 354 281
0.8 0.5 1.0 1.0 4.9 0.0 0.8
2.4 1.8 1.7 4.5 4.8
0.7 0.6 0.6 0.6
4.2 4.3 6.4 6.1 4.0
49 95 97 113 48 141 199 35 23
18 23 30 45 11 5.9 58 28 20
6.5 3.0 10 23 4.9 0.2 45 6.2 3.2
0.0 1.0 16 6.0 6.2 2.3 1.9 2.0 2.7
2.3 8.2 2.5
65 58 46 48 22 -113 -173 323 272
-115 -161 -198 -221 -319 -118 -182 -253 -333
28 28 28 34 42 34 34 36 36

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?